Sponsors

Introducing Omicron-reactive antibodies

The Omicron variant of the SARS-CoV-2 virus possesses multiple mutations in the spike protein. However, this variant also has mutations in the nucleocapsid protein (N).

This is critically important as current antigen tests detect the nucleocapsid by immunoassay. The antibodies employed in these tests must recognise the mutated N antigen otherwise a false-negative test will result.

ViroStat has validated its four best monoclonal antibody pairs (products #3865-#3868) for reactivity with the nucleocapsid of the Omicron variant. These high-affinity antibody pairs are used successfully in lateral flow and ELISA applications for antigen detection of the other variants as well.

Download the updated data sheet for these antibodies from the ViroStat website.

www.virostat-inc.com

Latest Issues

The British Association for Cytopathology Annual Scientific Meeting

Aztec Hotel and Spa, Bristol, BS32 4TS
18 October, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024

Pathology Visions 24

Hyatt Regency, Orlando, FL
3-5 November, 2025

Medica

Messe Dusseldorf
11-14 November, 2024

POCT-for-Scot: Bringing the future to you

SEC Arena, Glasgow
14 November, 2024